#Japan #Tokyo #Pharma Innovations #4DIN #Real World Insight

4DIN Expands Research Support Platform Connecting Medical Institutions and Pharmaceutical Companies

4DIN, headquartered in the bustling Minato-ku of Tokyo, is on a mission to strengthen its platform that connects hospitals and pharmaceutical firms through the utilization of Real World Data (RWD). By offering the 'Real World Insight™ (RWI)' service, which provides insights derived from electronic medical records of university hospitals, the company is expanding its research network, which currently includes 27 universities across Japan.

One highlight of this initiative is the collaboration with Pfizer R&D and Chugai Pharmaceutical, which utilized RWI to explore demographics and eligibility criteria ahead of clinical trials. This pioneering case will be showcased at the upcoming healthTECH JAPAN 2026 event.

Key Event Details

The event is scheduled for October 7, 2026, from 16:00 to 17:00 at Pacifico Yokohama, F204. Attendance is free, but prior registration is required. Notable speakers at the seminar include:

• - Naho Takeuchi, Oncology Division, Pfizer R&D
• - Nashi Yamabuki, Biometrics Department, Chugai Pharmaceutical
• - Seihiko Takahashi, CEO of 4DIN
• - Yugo Goto, CSO of 4DIN

During the three-day event from October 7 to 9, attendees can visit booth H-05 for personalized consultations and access to a white paper regarding RWI.

Enhancing Decision-Making with Real World Data

Real World Insight™ effectively enhances decision-making quality and speed, working across multiple domains including:

• - Understanding diseases and patient journeys
• - Identifying collaborative research themes and partners
• - Designing studies based on research questions
• - Assessing trial feasibility

You can learn more about RWI here.

4DIN's Vision for the Future

The vision of 4DIN is clear: to create a decision-making foundation that interlinks research, clinical development, and evidence generation. 4DIN is dedicated to building networks that connect academic institutions and healthcare providers with pharmaceutical companies, utilizing medical data for research and evidence generation.

By leveraging the Real World Insight™ platform alongside its clinical data analysis support system, SIMPRESEARCH®, 4DIN aims to enhance the decision-making quality and speed for all stakeholders. This innovation is expected to foster a new cycle of research and development based on data, contributing to groundbreaking advancements in healthcare.

About 4DIN

4DIN's mission is to visualize life science data to benefit patients, the ultimate recipients of the innovations. The company is involved in the development, sales, maintenance, analysis, consultation, and academic research support of medical information analysis platforms. By connecting healthcare institutions, researchers, and companies, 4DIN supports the creation of new value based on evidence and data.

Company Overview

• - Company Name: 4DIN Inc.
• - CEO: Seihiko Takahashi
• - Established: June 2003
• - Location: 805, Shimbashi Ekimae Building No.1, 2-20-15 Shimbashi, Minato-ku, Tokyo, 105-0004, Japan
• - Website: 4DIN Website